Gilead Sciences, Inc.
GILD
Jodie situation report
Gilead Sciences, Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 37 directly disclosed connections are confirming.
- Revenue increased 4.4% versus the comparable filing period.
- Oncology Cell Therapy product sales decreased 12% to $407 million for the three months ended March 31, 2026, primarily due to lower demand reflecting ongoing competitive headwinds.
- Trodelvy product sales increased 37% to $402 million for the three months ended March 31, 2026, primarily due to higher demand, favorable inventory dynamics and higher average realized price.
Invalidation: The isolated read changes if GILD's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind GILD
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
KYMRKymera Therapeutics, Inc.partnerFeb 24, 2026 ▾
“Entered into an exclusive option and license agreement with Kymera Therapeutics, Inc.”
RCUSArcus Biosciences, Inc.investeeMay 7, 2026 ▾
“For equity investments in our strategic partners, such as in connection with our collaborations with Arcus Biosciences, Inc.”
Depended on by
ASMBAssembly Biosciences, Inc.partnerMay 7, 2026 ▾
“In addition, our collaboration with Gilead also brings us an industry-leading partner and brings together the teams’ expertise in virology and provides an established partner for late-stage development and commercialization.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 35 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
GILD is currently a Leader in the organic co-movement group Drug Manufacturers. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for GILD; it is not active in the latest market snapshot.